SBI Biotech Co., Ltd. - Product Pipeline Review - 2015

  • ID: 3507635
  • Company Profile
  • 23 pages
  • Global Markets Direct
1 of 4
SBI Biotech Co., Ltd. - Product Pipeline Review - 2015

Summary

The authors, ‘SBI Biotech Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the SBI Biotech Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of SBI Biotech Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The authors report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from The authors proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by The authors team. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of SBI Biotech Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of SBI Biotech Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the SBI Biotech Co., Ltd.’s pipeline products

Reasons to buy

- Evaluate SBI Biotech Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of SBI Biotech Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the SBI Biotech Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of SBI Biotech Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of SBI Biotech Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of SBI Biotech Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

SBI Biotech Co., Ltd. Snapshot

SBI Biotech Co., Ltd. Overview

Key Information

Key Facts

SBI Biotech Co., Ltd. - Research and Development Overview

Key Therapeutic Areas

SBI Biotech Co., Ltd. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

SBI Biotech Co., Ltd. - Pipeline Products Glance

SBI Biotech Co., Ltd. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

SBI Biotech Co., Ltd. - Drug Profiles

GNKS-356

Product Description

Mechanism of Action

R&D Progress

SBI-3150

Product Description

Mechanism of Action

R&D Progress

SBI-9674

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit Cdc7/ASK for Oncology

Product Description

Mechanism of Action

R&D Progress

SBI Biotech Co., Ltd. - Pipeline Analysis

SBI Biotech Co., Ltd. - Pipeline Products by Target

SBI Biotech Co., Ltd. - Pipeline Products by Molecule Type

SBI Biotech Co., Ltd. - Pipeline Products by Mechanism of Action

SBI Biotech Co., Ltd. - Dormant Projects

SBI Biotech Co., Ltd. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

GNKG-168

SBI Biotech Co., Ltd. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

List of Tables

SBI Biotech Co., Ltd., Key Information

SBI Biotech Co., Ltd., Key Facts

SBI Biotech Co., Ltd. - Pipeline by Indication, 2015

SBI Biotech Co., Ltd. - Pipeline by Stage of Development, 2015

SBI Biotech Co., Ltd. - Monotherapy Products in Pipeline, 2015

SBI Biotech Co., Ltd. - Out-Licensed Products in Pipeline, 2015

SBI Biotech Co., Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2015

SBI Biotech Co., Ltd. - Preclinical, 2015

SBI Biotech Co., Ltd. - Pipeline by Target, 2015

SBI Biotech Co., Ltd. - Pipeline by Molecule Type, 2015

SBI Biotech Co., Ltd. - Pipeline Products by Mechanism of Action, 2015

SBI Biotech Co., Ltd. - Dormant Developmental Projects,2015

SBI Biotech Co., Ltd. - Discontinued Pipeline Products, 2015

SBI Biotech Co., Ltd., Subsidiaries

List of Figures

SBI Biotech Co., Ltd. - Pipeline by Top 10 Indication, 2015

SBI Biotech Co., Ltd. - Pipeline by Top 10 Target, 2015

SBI Biotech Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015

SBI Biotech Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll